Combined Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Combined Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: Study to Evaluate the Bioequivalence of "Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)" and "Crestor Tablet 5 mg (Rosuvastatin Calcium)" in Healthy Adult Subjects [Phase 1]
Phase 1 bioequivalence study comparing Crecheck Tablet 2.5 mg rosuvastatin calcium with Crestor Tablet 5 mg rosuvastatin calcium in healthy …
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: "Phospholipovit" vs Placebo in Patients With Combined Hyperlipidemia [Phase 2, Phase 3]
Phase 2/3 clinical trial comparing Phospholipovit to placebo in patients with combined hyperlipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-24Clinical Trial Update: A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia [Phase 3]
A Phase 3 clinical trial comparing daily pravastatin, fenofibrate, and the combination Pravafen for treating combined hyperlipidemia has com…
-
CLINICAL_TRIALS trial_result · 2006-07-21Clinical Trial Update: Cholesterol-Lowering Effects of Policosanol [Phase 3]
A Phase 3 trial evaluating policosanol for lowering cholesterol was terminated; no efficacy or safety results are provided in this update.